EVFM
Evofem Biosciences, Inc.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 203,117 |
Stock Information
| Shares Outstanding | 132.53M |
| Total Debt | $52.46M |
| Cash Equivalents | $1.62M |
| Revenue | $20.24M |
| Net Income | $-6.16M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.19M |
| EPS (TTM) | $-0.05 |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $56.88M |
| Sales | $20.24M |
| Income | $-6.16M |
| Book/sh | $-0.59 |
| Cash/sh | $0.01 |
| Employees | 29 |
Financial Ratios
| Quick Ratio | 0.03 |
| Current Ratio | 0.08 |
Returns & Margins
| ROA | -21.27% |
| Gross Margin | 76.96% |
| Operating Margin | -508.23% |
| Profit Margin | -29.80% |
Ownership
| Insider Ownership | 0.00% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.02 |
| P/S | 0.06 |
| P/B | -0.02 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.01 |
| RSI | 62.50 |
| ATR | 0.0013 |
| Shares Float | 132.53M |
| Short Float | 11.01% |
| Short Ratio | 0.19 |
| Volatility | -1.28 |
| Rel Volume | 1.63 |
Performance History
| Week | +28.57% |
| Month | +50.00% |
| Quarter | +0.00% |
| 6 Months | -10.00% |
| YTD | -10.00% |
| Year | -10.00% |
| 3 Years | -99.07% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.01 | 451,400 |
| 2026-06-17 | $0.01 | 588,200 |
| 2026-06-16 | $0.01 | 164,800 |
| 2026-06-15 | $0.01 | 790,700 |
| 2026-06-12 | $0.01 | 405,900 |
| 2026-06-11 | $0.01 | 34,400 |
| 2026-06-10 | $0.01 | 63,500 |
| 2026-06-09 | $0.01 | 68,100 |
| 2026-06-08 | $0.01 | 45,200 |
| 2026-06-05 | $0.01 | 83,200 |
| 2026-06-04 | $0.01 | 753,700 |
| 2026-06-03 | $0.01 | 756,600 |
| 2026-06-02 | $0.01 | 142,300 |
| 2026-06-01 | $0.01 | 385,600 |
| 2026-05-29 | $0.01 | 114,200 |
| 2026-05-28 | $0.01 | 16,000 |
| 2026-05-27 | $0.01 | 46,100 |
| 2026-05-26 | $0.01 | 89,600 |
| 2026-05-22 | $0.01 | 511,100 |
| 2026-05-21 | $0.01 | 44,600 |
| 2026-05-20 | $0.01 | 193,200 |
| 2026-05-19 | $0.01 | 163,700 |
About Evofem Biosciences, Inc.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,697,000 | $4,731,000 | $4,415,000 | $4,055,000 |
| Cost Of Revenue | $3,834,000 | $6,512,000 | $4,415,000 | $4,055,000 |
| Total Revenue | $19,363,000 | $18,218,000 | $16,837,000 | $8,244,000 |
| Operating Revenue | $19,363,000 | $18,218,000 | $16,837,000 | $8,244,000 |
| Expenses | ||||
| Total Expenses | $27,039,000 | $36,065,000 | $100,961,000 | $175,045,000 |
| Other Income Expense | $-1,200,000 | $70,812,000 | $7,385,000 | $-38,389,000 |
| Other Non Operating Income Expenses | $-2,575,000 | $-2,628,000 | $-2,087,000 | $-4,732,000 |
| Net Non Operating Interest Income Expense | $16,000 | $31,000 | $85,000 | $15,000 |
| Operating Expense | $23,205,000 | $29,553,000 | $96,546,000 | $170,990,000 |
| Selling And Marketing Expense | $9,176,000 | $11,664,000 | $43,951,000 | $113,152,000 |
| General And Administrative Expense | $11,565,000 | $14,950,000 | $27,563,000 | $24,709,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-8,860,000 | $52,979,000 | $-76,698,000 | $-205,192,000 |
| Net Interest Income | $16,000 | $31,000 | $85,000 | $15,000 |
| Interest Income | $16,000 | $31,000 | $85,000 | $15,000 |
| Normalized Income | $-10,235,000 | $-20,453,656 | $-84,180,880 | $-180,622,390 |
| Net Income From Continuing And Discontinued Operation | $-8,860,000 | $52,979,000 | $-76,698,000 | $-205,192,000 |
| Total Operating Income As Reported | $-7,676,000 | $-17,847,000 | $-84,124,000 | $-166,801,000 |
| Net Income Common Stockholders | $-8,965,000 | $49,995,000 | $-78,014,000 | $-206,239,000 |
| Net Income | $-8,860,000 | $52,979,000 | $-76,698,000 | $-205,192,000 |
| Net Income Including Noncontrolling Interests | $-8,860,000 | $52,979,000 | $-76,698,000 | $-205,192,000 |
| Net Income Continuous Operations | $-8,860,000 | $52,979,000 | $-76,698,000 | $-205,192,000 |
| Pretax Income | $-8,860,000 | $52,996,000 | $-76,654,000 | $-205,175,000 |
| Special Income Charges | $977,000 | $75,337,000 | $-24,487,000 | - |
| Interest Income Non Operating | $16,000 | $31,000 | $85,000 | $15,000 |
| Operating Income | $-7,676,000 | $-17,847,000 | $-84,124,000 | $-166,801,000 |
| Depreciation Amortization Depletion Income Statement | $619,000 | $0 | - | - |
| Depreciation And Amortization In Income Statement | $619,000 | $0 | - | - |
| Amortization Of Intangibles Income Statement | $619,000 | $0 | - | - |
| Gross Profit | $15,529,000 | $11,706,000 | $12,422,000 | $4,189,000 |
| Per Share | ||||
| Diluted EPS | $-0.12 | $0.05 | $-167.50 | $-2962.49 |
| Basic EPS | $-0.12 | $10.36 | $-167.50 | $-2962.49 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $7,344 | $1,989,120 | $-9,087,390 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,295,000 | $-89,506,000 | $-91,550,000 | $-132,121,000 |
| Total Unusual Items | $1,375,000 | $73,440,000 | $9,472,000 | $-33,657,000 |
| Total Unusual Items Excluding Goodwill | $1,375,000 | $73,440,000 | $9,472,000 | $-33,657,000 |
| Reconciled Depreciation | $756,000 | $1,781,000 | $2,046,000 | $1,023,000 |
| EBITDA (Bullshit earnings) | $-6,920,000 | $-16,066,000 | $-82,078,000 | $-165,778,000 |
| EBIT | $-7,676,000 | $-17,847,000 | $-84,124,000 | $-166,801,000 |
| Diluted Average Shares | $75,195,615 | $984,038,574 | $465,984 | $69,818 |
| Basic Average Shares | $75,195,615 | $4,826,763 | $465,984 | $69,818 |
| Diluted NI Availto Com Stockholders | $-8,965,000 | $49,995,000 | $-78,014,000 | $-206,239,000 |
| Preferred Stock Dividends | $105,000 | $2,984,000 | $1,316,000 | $1,047,000 |
| Tax Provision | $0 | $17,000 | $44,000 | $17,000 |
| Other Special Charges | $-977,000 | $-75,337,000 | $24,487,000 | - |
| Gain On Sale Of Security | $398,000 | $-1,897,000 | $33,959,000 | $-33,657,000 |
| Amortization | $619,000 | $0 | - | - |
| Research And Development | $1,845,000 | $2,939,000 | $25,032,000 | $33,129,000 |
| Selling General And Administration | $20,741,000 | $26,614,000 | $71,514,000 | $137,861,000 |
| Other Gand A | $11,565,000 | $14,950,000 | $27,563,000 | $24,709,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-80,854,000 | $-66,510,000 | $-71,800,000 | $-99,575,000 |
| Total Assets | $23,789,000 | $10,554,000 | $25,163,000 | $42,512,000 |
| Total Non Current Assets | $10,180,000 | $1,344,000 | $12,464,000 | $12,372,000 |
| Other Non Current Assets | $36,000 | $35,000 | $2,401,000 | $1,094,000 |
| Goodwill And Other Intangible Assets | $9,597,000 | $0 | - | - |
| Other Intangible Assets | $9,597,000 | - | - | - |
| Current Assets | $13,609,000 | $9,210,000 | $12,699,000 | $30,140,000 |
| Other Current Assets | $1,332,000 | $1,119,000 | $2,218,000 | $1,773,000 |
| Restricted Cash | $741,000 | $580,000 | $1,207,000 | $5,056,000 |
| Prepaid Assets | $127,000 | $76,000 | $1,790,000 | $1,456,000 |
| Inventory | $1,577,000 | $1,697,000 | $5,379,000 | $7,674,000 |
| Receivables | $9,832,000 | $5,738,000 | $1,126,000 | $6,449,000 |
| Accounts Receivable | $9,832,000 | $5,738,000 | $1,126,000 | $6,449,000 |
| Cash Cash Equivalents And Short Term Investments | $0 | $0 | $2,769,000 | $7,732,000 |
| Cash And Cash Equivalents | $0 | $0 | $2,769,000 | $7,732,000 |
| Non Current Prepaid Assets | - | $0 | $1,717,000 | $109,000 |
| Notes Receivable | - | - | - | $0 |
| Debt | ||||
| Net Debt | $45,878,000 | $43,268,000 | $62,915,000 | $101,194,000 |
| Total Debt | $45,967,000 | $43,373,000 | $71,128,000 | $115,682,000 |
| Long Term Debt And Capital Lease Obligation | $7,000 | $8,000 | $3,133,000 | $4,424,000 |
| Current Debt And Capital Lease Obligation | $45,960,000 | $43,365,000 | $67,995,000 | $111,258,000 |
| Current Debt | $45,878,000 | $43,268,000 | $65,684,000 | $108,926,000 |
| Other Current Borrowings | $45,878,000 | $43,268,000 | $65,684,000 | $108,926,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $95,046,000 | $77,064,000 | $96,963,000 | $142,087,000 |
| Total Non Current Liabilities Net Minority Interest | $14,598,000 | $4,601,000 | $3,133,000 | $4,424,000 |
| Other Non Current Liabilities | $9,809,000 | - | - | - |
| Current Liabilities | $80,448,000 | $72,463,000 | $93,830,000 | $137,663,000 |
| Other Current Liabilities | $9,313,000 | $5,242,000 | $4,552,000 | $3,066,000 |
| Payables And Accrued Expenses | $21,681,000 | $21,247,000 | $19,108,000 | $18,686,000 |
| Payables | $16,172,000 | $17,020,000 | $14,984,000 | $10,316,000 |
| Accounts Payable | $16,172,000 | $17,020,000 | $14,984,000 | $10,316,000 |
| Equity | ||||
| Common Stock Equity | $-71,257,000 | $-66,510,000 | $-71,800,000 | $-104,315,000 |
| Total Equity Gross Minority Interest | $-71,257,000 | $-66,510,000 | $-71,800,000 | $-99,575,000 |
| Stockholders Equity | $-71,257,000 | $-66,510,000 | $-71,800,000 | $-99,575,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,630,000 | $-849,000 | $49,527,000 | $5,089,000 |
| Other Equity Adjustments | $-2,630,000 | $-849,000 | $49,527,000 | $5,089,000 |
| Retained Earnings | $-897,664,000 | $-888,699,000 | $-938,694,000 | $-860,680,000 |
| Preferred Securities Outside Stock Equity | $4,782,000 | $4,593,000 | $0 | $0 |
| Preferred Stock Equity | - | - | - | $4,740,000 |
| Other | ||||
| Ordinary Shares Number | $113,356,354 | $20,007,799 | $984,786 | $86,667 |
| Share Issued | $113,356,354 | $20,007,799 | $984,786 | $86,667 |
| Tangible Book Value | $-80,854,000 | $-66,510,000 | $-71,800,000 | $-104,315,000 |
| Invested Capital | $-25,379,000 | $-23,242,000 | $-6,116,000 | $4,611,000 |
| Working Capital | $-66,839,000 | $-63,253,000 | $-81,131,000 | $-107,523,000 |
| Capital Lease Obligations | $89,000 | $105,000 | $5,444,000 | $6,756,000 |
| Total Capitalization | $-71,257,000 | $-66,510,000 | $-71,800,000 | $-99,575,000 |
| Additional Paid In Capital | $829,026,000 | $823,036,000 | $817,367,000 | $751,260,000 |
| Capital Stock | $11,000 | $2,000 | $0 | $4,756,000 |
| Common Stock | $11,000 | $2,000 | $0 | $16,000 |
| Preferred Stock | $0 | $0 | $0 | $4,740,000 |
| Long Term Capital Lease Obligation | $7,000 | $8,000 | $3,133,000 | $4,424,000 |
| Current Capital Lease Obligation | $82,000 | $97,000 | $2,311,000 | $2,332,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $3,494,000 | $2,609,000 | $2,175,000 | $4,653,000 |
| Current Accrued Expenses | $5,509,000 | $4,227,000 | $4,124,000 | $8,370,000 |
| Net PPE | $547,000 | $1,309,000 | $8,346,000 | $11,169,000 |
| Accumulated Depreciation | $-701,000 | $-1,186,000 | $-3,189,000 | $-2,174,000 |
| Gross PPE | $1,248,000 | $2,495,000 | $11,535,000 | $13,343,000 |
| Construction In Progress | $429,000 | $1,156,000 | $1,568,000 | $2,407,000 |
| Other Properties | $674,000 | $692,000 | $5,059,000 | $6,048,000 |
| Machinery Furniture Equipment | $145,000 | $647,000 | $1,520,000 | $1,500,000 |
| Finished Goods | $245,000 | $791,000 | - | - |
| Work In Process | $982,000 | $386,000 | - | - |
| Raw Materials | $350,000 | $520,000 | - | - |
| Leases | - | $0 | $3,388,000 | $3,388,000 |
| Properties | - | $0 | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,899,000 | $-8,972,000 | $-70,751,000 | $-149,606,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-3,885,000 | $-8,968,000 | $-70,410,000 | $-146,667,000 |
| Cash Flow From Continuing Operating Activities | $-3,885,000 | $-8,968,000 | $-70,410,000 | $-146,667,000 |
| Operating Gains Losses | $3,057,000 | $-68,146,000 | $98,920,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-14,000 | $-4,000 | $-341,000 | $-2,939,000 |
| Investing Cash Flow | $-569,000 | $-4,000 | $-341,000 | $-2,689,000 |
| Cash Flow From Continuing Investing Activities | $-569,000 | $-4,000 | $-341,000 | $-2,689,000 |
| Net Other Investing Changes | $-555,000 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $5,000,000 | $0 | $32,320,000 | $91,534,000 |
| Financing Cash Flow | $4,615,000 | $4,776,000 | $61,939,000 | $90,693,000 |
| Cash Flow From Continuing Financing Activities | $4,615,000 | $4,776,000 | $61,939,000 | $90,693,000 |
| Net Common Stock Issuance | $5,000,000 | $0 | $32,302,000 | $81,534,000 |
| Common Stock Issuance | $5,000,000 | $0 | $32,320,000 | $81,534,000 |
| Repurchase Of Capital Stock | - | $0 | $-18,000 | $0 |
| Net Other Financing Charges | - | - | $-1,202,000 | $-1,297,000 |
| Net Preferred Stock Issuance | - | - | $0 | $10,000,000 |
| Preferred Stock Issuance | - | - | $0 | $10,000,000 |
| Other | ||||
| Repayment Of Debt | $-782,000 | $-1,154,000 | $-5,892,000 | $0 |
| Issuance Of Debt | $397,000 | $5,640,000 | $11,500,000 | $0 |
| Interest Paid Supplemental Data | $159,000 | $338,000 | $698,000 | $1,389,000 |
| Income Tax Paid Supplemental Data | $8,000 | $4,000 | $26,000 | $11,000 |
| End Cash Position | $741,000 | $580,000 | $4,776,000 | $13,588,000 |
| Beginning Cash Position | $580,000 | $4,776,000 | $13,588,000 | $72,251,000 |
| Changes In Cash | $161,000 | $-4,196,000 | $-8,812,000 | $-58,663,000 |
| Proceeds From Stock Option Exercised | $0 | $290,000 | $25,231,000 | $456,000 |
| Net Issuance Payments Of Debt | $-385,000 | $4,486,000 | $5,608,000 | $0 |
| Net Short Term Debt Issuance | $-385,000 | $4,486,000 | - | - |
| Short Term Debt Payments | $-782,000 | $-1,154,000 | - | - |
| Short Term Debt Issuance | $397,000 | $5,640,000 | - | - |
| Net PPE Purchase And Sale | $-14,000 | $-4,000 | $-341,000 | $-2,939,000 |
| Purchase Of PPE | $-14,000 | $-4,000 | $-341,000 | $-2,939,000 |
| Change In Working Capital | $867,000 | $4,728,000 | $6,018,000 | $10,578,000 |
| Change In Other Current Liabilities | $-106,000 | $-1,478,000 | $-1,354,000 | $-1,507,000 |
| Change In Payables And Accrued Expense | $5,275,000 | $5,051,000 | $-2,110,000 | $3,606,000 |
| Change In Accrued Expense | $6,185,000 | $961,000 | $-6,584,000 | $3,610,000 |
| Change In Payable | $-910,000 | $4,090,000 | $4,474,000 | $-4,000 |
| Change In Account Payable | $-910,000 | $4,090,000 | $4,474,000 | $-4,000 |
| Change In Prepaid Assets | $-265,000 | $3,661,000 | $2,593,000 | $13,882,000 |
| Change In Inventory | $57,000 | $2,106,000 | $1,566,000 | $-21,000 |
| Change In Receivables | $-4,094,000 | $-4,612,000 | $5,323,000 | $-5,382,000 |
| Changes In Account Receivables | $-4,094,000 | $-4,612,000 | $5,323,000 | $-5,382,000 |
| Other Non Cash Items | $3,083,000 | $1,804,000 | $3,243,000 | $4,069,000 |
| Stock Based Compensation | $847,000 | $1,189,000 | $3,313,000 | $8,898,000 |
| Unrealized Gain Loss On Investment Securities | $-3,698,000 | $-4,879,000 | $-106,952,000 | $33,657,000 |
| Asset Impairment Charge | $63,000 | $1,576,000 | - | - |
| Depreciation Amortization Depletion | $756,000 | $1,781,000 | $2,046,000 | $1,023,000 |
| Depreciation And Amortization | $756,000 | $1,781,000 | $2,046,000 | $1,023,000 |
| Amortization Cash Flow | $619,000 | $0 | - | - |
| Amortization Of Intangibles | $619,000 | $0 | - | - |
| Depreciation | $137,000 | $1,781,000 | $2,046,000 | $1,023,000 |
| Gain Loss On Investment Securities | $3,300,000 | $6,776,000 | $72,993,000 | - |
| Gain Loss On Sale Of PPE | $734,000 | $2,511,000 | $926,000 | $0 |
| Net Income From Continuing Operations | $-8,860,000 | $52,979,000 | $-76,698,000 | $-205,192,000 |
| Common Stock Payments | - | $0 | $-18,000 | $0 |
| Net Long Term Debt Issuance | - | $4,486,000 | $5,608,000 | $0 |
| Long Term Debt Payments | - | $-1,154,000 | $-5,892,000 | $0 |
| Long Term Debt Issuance | - | $5,640,000 | $11,500,000 | $0 |
| Change In Other Working Capital | - | $434,000 | $-2,478,000 | $-1,861,000 |
| Provisionand Write Offof Assets | - | $1,576,000 | $-300,000 | $300,000 |
| Net Foreign Currency Exchange Gain Loss | - | $0 | $514,000 | $0 |
| Net Investment Purchase And Sale | - | - | $0 | $0 |
| Sale Of Investment | - | - | $0 | $0 |
| Net Business Purchase And Sale | - | - | $0 | $250,000 |
| Sale Of Business | - | - | $0 | $250,000 |
Fetched: 2026-02-02